Holen Sie sich die Stockscreener-App
2.01
4.29%
-0.09
Vorhandelsmarkt:
1.98
-0.03
-1.49%
Schlusskurs vom Vortag:
$2.10
Offen:
$2.02
24-Stunden-Volumen:
111.30K
Relative Volume:
1.11
Marktkapitalisierung:
$5.44M
Einnahmen:
$202.00K
Nettoeinkommen (Verlust:
$-28.96M
KGV:
-3.35
EPS:
-0.6
Netto-Cashflow:
$-21.85M
1W Leistung:
-23.28%
1M Leistung:
-23.86%
6M Leistung:
+2,018%
1J Leistung:
+669.82%
1-Tages-Spanne:
$2.00
$2.10
1-Wochen-Bereich:
$2.00
$2.63
52-Wochen-Spanne:
$0.0633
$20.35
AIM ImmunoTech Inc Stock (AIM) Company Profile
Firmenname
AIM ImmunoTech Inc
Sektor
Branche
Telefon
352 448 7797
Adresse
2117 SW Highway 484, Ocala, FL
Vergleichen Sie AIM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AIM
AIM ImmunoTech Inc
|
2.01 | 5.80M | 202.00K | -28.96M | -21.85M | -0.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
AIM ImmunoTech Inc Aktie (AIM) Neueste Nachrichten
Is AIM ImmunoTech Inc. stock supported by strong fundamentals2025 Risk Factors & Low Risk High Reward Ideas - newser.com
Is AIM ImmunoTech Inc. stock vulnerable to rate hikesMarket Volume Summary & Smart Investment Allocation Insights - newser.com
Is AIM ImmunoTech Inc. (HXB) stock resilient in recession scenarios2025 Bull vs Bear & Smart Money Movement Alerts - newser.com
How forex fluctuations impact AIM ImmunoTech Inc. stockJuly 2025 Update & AI Optimized Trading Strategy Guides - newser.com
Can AIM ImmunoTech Inc. (HXB) stock hit consensus price targetsEarnings Recap Summary & Smart Money Movement Alerts - newser.com
AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue - The Manila Times
AIM ImmunoTech Announces European Patent Office Grants - GlobeNewswire
AIM ImmunoTech (NYSE American: AIM) gains EU patent for Ampligen in post‑COVID fatigue - Stock Titan
What downside risks could hit AIM ImmunoTech Inc. (HXB) stockIndex Update & Low Risk High Reward Ideas - newser.com
Can AIM ImmunoTech Inc. stock expand revenue streamsEarnings Risk Summary & Free Weekly Watchlist of Top Performers - newser.com
How AIM ImmunoTech Inc. stock stacks up against competitors2025 Price Action Summary & Safe Entry Trade Reports - newser.com
Why AIM ImmunoTech Inc. stock attracts HNW investorsWeekly Investment Report & Entry Point Strategy Guides - newser.com
Is AIM ImmunoTech Inc. stock dividend growth reliableNew Guidance & Verified Swing Trading Watchlist - newser.com
How buyback programs support AIM ImmunoTech Inc. (HXB) stock2025 EndofYear Setup & Community Consensus Stock Picks - newser.com
Finanzdaten der AIM ImmunoTech Inc-Aktie (AIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):